Flexion Therapeutics reported $5.18M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Aerie Pharmaceuticals AERI:US $ 7.12M 0.22M
Ani Pharmaceuticals ANIP:US $ 2.53M 77K
Arena Pharmaceuticals ARNA:US $ 1.05M 0.02M
Chemocentryx CCXI:US $ 0.7M 0.01M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Emergent Biosolutions EBS:US $ 8.6M 0.1M
Endo International Ordinary Shares ENDP:US $ 141.64M 6.95M
Esperion Therapeutics ESPR:US $ 11.14M 3.02M
Flexion Therapeutics FLXN:US $ 5.18M 9K
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
Immunogen IMGN:US $ 3.58M 1.09M
Insmed INSM:US $ 10.32M 2.76M
Ironwood Pharmaceuticals IRWD:US $ 7.73M 0.11M
JAZZ PHA JAZZ:US $ 69.82M 41.24M
Karyopharm Therapeutics KPTI:US $ 5M 94K
Lannett LCI:US $ 13.22M 0.59M
Pacira Pharmaceuticals PCRX:US $ 7.02M 0.05M
Pfizer PFE:US $ 316M 20M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Revance Therapeutics RVNC:US $ 1.57M 9K
Teva Pharmaceutical Industries TEVA:US $ 240M 1M
Zogenix ZGNX:US $ 3.79M 0.05M